Isolation of the UDP-glucuronosyltransferase 1A3 and 1A4 proximal promoters and characterization of their dependence on the transcription factor hepatocyte nuclear factor 1α

被引:28
作者
Gardner-Stephen, Dione A. [1 ]
Mackenzie, Peter I. [1 ]
机构
[1] Flinders Univ S Australia, Sch Med, Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia
关键词
D O I
10.1124/dmd.106.012203
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The UGT1A3-1A5 genes are a highly related UDP-glucuronosyl-transferase (UGT) cluster exhibiting high levels of coding and regulatory region homology. However, the ensuing proteins have both differing substrate specificities and differing expression patterns. The expression profile of each enzyme also varies considerably from one individual to the next. Differences in UGT expression have been predicted to contribute to an individual's response to pharmaceuticals and to predisposition toward cancer in the event of carcinogen exposure. Therefore, it is desirable to elucidate the mechanisms that drive the transcription of UGT genes and identify the factors responsible for their variable expression. To this end, we have isolated the UGT1A3, UGT1A4, and UGT1A5 proximal promoters and begun to investigate the regulatory elements necessary for activity in vitro. We have established that the nucleotide sequence upstream of the UGT1A5 exon 1 is an ineffective promoter, correlating with the lack of substantial expression of this UGT in human tissues. In contrast, the UGT1A3 and UGT1A4 proximal promoters are both highly active in hepatic and colonic cell lines, with maximal activity being encoded by the proximal 500 base pairs. However, the UGT1A3 and UGT1A4 promoters exhibit low activity in the human embryonic kidney cell line HEK293, unless coexpressed with hepatocyte nuclear factor (HNF) 1 alpha. Furthermore, mutation of the consensus-like HNF1-binding site in the UGT1A3 promoter abolishes promoter function in all cell types. This study suggests an important role for HNF1 alpha in the transcriptional regulation of the human UGT1A3 and UGT1A4 genes.
引用
收藏
页码:116 / 120
页数:5
相关论文
共 17 条
[1]   Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1 [J].
Bernard, P ;
Goudonnet, H ;
Artur, Y ;
Desvergne, B ;
Wahli, W .
MOLECULAR PHARMACOLOGY, 1999, 56 (03) :526-536
[2]   Inactivation of the pure antiestrogen fulvestrant and other synthetic estrogen molecules by UDP-glucuronosyltransferase 1A enzymes expressed in breast tissue [J].
Chouinard, S ;
Tessier, M ;
Vernouillet, G ;
Gauthier, S ;
Labrie, F ;
Barbier, O ;
Bélanger, A .
MOLECULAR PHARMACOLOGY, 2006, 69 (03) :908-920
[3]   Human UDP-Glucuronosyltransferase 1A5: Identification, expression, and activity [J].
Finel, M ;
Li, X ;
Gardner-Stephen, D ;
Bratton, S ;
Mackenzie, PI ;
Radominska-Pandya, A .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1143-1149
[4]   Identification and characterization of functional hepatocyte nuclear factor 1-binding sites in UDP-glucuronosyltransferase genes [J].
Gardner-Stephen, DA ;
Gregory, PA ;
Mackenzie, PI .
PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 :22-46
[5]   Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus [J].
Gong, QH ;
Cho, JW ;
Huang, T ;
Potter, C ;
Gholami, N ;
Basu, NK ;
Kubota, S ;
Carvalho, S ;
Pennington, MW ;
Owens, IS ;
Popescu, NC .
PHARMACOGENETICS, 2001, 11 (04) :357-368
[6]  
Green MD, 1998, DRUG METAB DISPOS, V26, P860
[7]   Cloning and characterization of the human UDP-glucuronosyltransferase 1A8, 1A9, and 1A10 gene promoters - Differential regulation through an initiator-like region [J].
Gregory, PA ;
Gardner-Stephen, DA ;
Lewinsky, RH ;
Duncliffe, KN ;
Mackenzie, PI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (38) :36107-36114
[8]   MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND CHROMOSOMAL LOCALIZATION OF MOUSE HEPATOCYTE NUCLEAR FACTOR-I [J].
KUO, CJ ;
CONLEY, PB ;
HSIEH, CL ;
FRANCKE, U ;
CRABTREE, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9838-9842
[9]  
Mackenzie P. I., 2005, TOXICOL APPL PHARM, V207, P77, DOI DOI 10.1016/J.TAAP.2004.12.026
[10]   Structural and functional studies of UDP-glucuronosyltransferases [J].
Radominska-Pandya, A ;
Czernik, PJ ;
Little, JM ;
Battaglia, E ;
Mackenzie, PI .
DRUG METABOLISM REVIEWS, 1999, 31 (04) :817-899